Journal profile · Pharmacology & Pharmacy
Drug Metabolism and Pharmacokinetics
ISSN 1347-4367 · eISSN 1880-0920 · Japanese Society for the Study of Xenobiotics · JAPAN · Bimonthly · Founded 2002
Drug Metabolism and Pharmacokinetics: CAS Zone 4 · Medicine (2025 upgraded edition); impact factor 2.13; fully open access; APC about USD 3,580; median 102 days to acceptance (75 articles, last 24 months); community-reported acceptance: about 75%; 454 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
Drug Metabolism and Pharmacokinetics is published by Japanese Society for the Study of Xenobiotics and is in Zone 4 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Pharmacogenetics and Drug Metabolism, Drug Transport and Resistance Mechanisms and Computational Drug Discovery Methods, together about 44.4% of its articles. (generated from OpenAlex topic counts and CAS ranking data)
Official Online Journal of the Japanese Society for the Study of Xenobiotics and the International Society for the Study of XenobioticsDrug Metabolism and Pharmacokinetics (DMPK) is an official online journal of the Japanese Society for the Study of Xenobiotics (JSSX) and the International Society for the Study of Xenobiotics (ISSX), and it replaces the JSSX's former journal, Xenobiotic Metabolism and Disposition. The journal will accept original submissions in English on the understanding that the work is unpublished and is not being considered for publication elsewhere.Scope of submitted manuscripts DMPK publishes original and innovative scientific papers that address topics broadly related to xenobiotics. The term xenobiotic includes medicinal as well as environmental and agricultural chemicals and macromolecules. The journal is organized into sections as follows: - Drug metabolism / Biotransformation - Pharmacokinetics and pharmacodynamics - Toxicokinetics and toxicodynamics - Drug-drug interaction / Drug-food interaction - Mechanism of drug absorption and disposition (including transporter) - Drug delivery system - Clinical pharmacy and pharmacology - Analytical method - Factors affecting drug metabolism and transport - Expression of genes for drug-metabolizing enzymes and transporters - Pharmacogenetics and pharmacogenomics - Pharmacoepidemiology
From the journal's Aims & Scope
Research area (LetPub): Pharmacology & Pharmacy
Editor-in-chief Kiyomi ItoPublisher website
Editorial board by country: 1 in mainland China (about 3%); most named Japan 20, South Korea 6, United States 3, United Kingdom 2, Thailand 2 (34 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Pharmacogenetics and Drug MetabolismPharmacology, Toxicology and Pharmaceutics20.2%
- Drug Transport and Resistance MechanismsMedicine18.1%
- Computational Drug Discovery MethodsComputer Science6.1%
- Pharmacological Effects and Toxicity StudiesMedicine5.7%
- Drug-Induced Hepatotoxicity and ProtectionPharmacology, Toxicology and Pharmaceutics3.9%
- Metabolism and Genetic DisordersBiochemistry, Genetics and Molecular Biology3.8%
- Metabolomics and Mass Spectrometry StudiesBiochemistry, Genetics and Molecular Biology3.4%
- Liver Disease Diagnosis and TreatmentMedicine3.3%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Pharmacology & Pharmacy | Zone 4 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Pharmacology & Pharmacy | Zone 4 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Pharmacology & Pharmacy | Zone 4 |
Top journal: noReview journal: no
Database indexing
SCIEScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
PubMedPublisher website
Other: Crossref
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 2.13LetPub ·
- Impact factor (publisher)
- 2.2Publisher website ·
- CiteScore 2026-06
- 5.2LetPub ·
- CiteScore (publisher)
- 5.2Publisher website ·
- SJR 2026-06
- 0.63LetPub ·
- SNIP 2026-06
- 0.76LetPub ·
- h-index
- 58LetPub ·
- h-index
- 86OpenAlex ·
- i10-index
- 899OpenAlex ·
- 2-year mean citedness
- 0.44OpenAlex ·
- Self-citation rate
- 9.1%LetPub ·
- Share of gold OA articles
- 18.75%LetPub ·
Volume
- Articles per year
- 36LetPub ·
Articles by year OpenAlex count · 3,499 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 35 | 9 | 18 |
| 2025 | 454 | 19 | 83 |
| 2024 | 301 | 48 | 243 |
| 2023 | 42 | 19 | 211 |
| 2022 | 42 | 27 | 425 |
| 2021 | 63 | 26 | 1,055 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with PubMed · to
102 daysMedian, submission to acceptance · P25–P75 62 days – 123 days
- Acceptance to online
- median 2 days (75 articles)
- Submission to online
- median 105 days
- Sample
- 75 articles with submission and acceptance dates (82 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- about 1 monthLetPub ·
- Average acceptance (community reports)
- 75%LetPub ·
- First decision after review
- 35 daysPublisher website ·
- Submission to acceptance
- 104 daysPublisher website ·
- Acceptance to publication
- 2 daysPublisher website ·
- Peer review
- Single anonymous peer reviewPublisher website
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Fully open accessLetPub
Every article is open access; authors usually pay an article processing charge (APC).
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| OpenAlex | USD 3,580 / EUR 3,350 / GBP 2,870 / JPY 444,030 | — | — | |
| Publisher website | JPY 8,000 / JPY 5,000 | — | — |
Other charges and waivers (author guidelines)
- Page charges
- Charged; see the journal's website for the amount
- Submission fee
- Charged; see the journal's website for the amount
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
What to prepare3 items from the author guidelines
- Abstract
- ≤ 200 words
- Keywords
- ≥ 5
- Manuscript length
- ≤ 5,500 words
Article types accepted5
- commentaryThe journal publishes Regular Articles, Notes, Reviews, White Paper and Commentary.Length not stated
- notesThe journal publishes Regular Articles, Notes, Reviews, White Paper and Commentary.Length not stated
- regular articlesThe journal publishes Regular Articles, Notes, Reviews, White Paper and Commentary.Length not stated
- reviewsThe journal publishes Regular Articles, Notes, Reviews, White Paper and Commentary.Length not stated
- white paperThe journal publishes Regular Articles, Notes, Reviews, White Paper and Commentary.Length not stated
Policy excerpts from the journal's websiteAI use, Authorship, Conflicts of interest, Open access, Peer review, Plagiarism, Preprints
- AI use Declaration of generative AI in scientific writing
Generative AI use must be declared upon submission; AI tools may support but not replace human critical thinking; AI cannot be listed as author. Model summary
Authors must declare the use of generative AI tools in the manuscript preparation process upon submission of the paper.Generative AI and AI-assisted technologies (“AI tools”) have been rapidly adopted in research and scholarly publishing, offering significant benefits while requiring clear standards for responsible and transparent use.Authors preparing a manuscript for this journal may use AI tool…
Source ↗Publisher website ·- Authorship Author contributions
Original work not published or under consideration elsewhere; publication approved by all authors. Model summary
For transparency, we require corresponding authors to provide co-author contributions to the manuscript using the relevant CRediT roles. The CRediT taxonomy includes 14 different roles describing each contributor's specific contribution to the scholarly output. The roles are: Conceptualization; Data curation; Formal analysis; Funding acquisition; Investigation; Methodology; Project administration;…
Source ↗Publisher website ·- Conflicts of interest Declaration of interest
Authors must disclose competing interests in a declaration statement and a separate form. Model summary
All authors must disclose any financial and personal relationships with other people or organizations that could inappropriately influence (bias) their work. Examples of potential competing interests include employment, consultancies, stock ownership, honoraria, paid expert testimony, patent applications/registrations, and grants or other funding. Authors must disclose any interests in two places:…
Source ↗Publisher website ·- Open access Open access
Open access option with CC BY-NC-ND license; publication fee payable by authors or funders. Model summary
Please visit our Open Access page for more information about open access publishing in this journal.This journal offers authors a choice in publishing their research:Open Access• Articles are freely available to both subscribers and the wider public with permitted reuse• An Open Access publication fee is payable by authors or their research funderSubscription• Articles are made available to subscr…
Source ↗Publisher website ·- Peer review Peer review
Single anonymized peer review; minimum two independent expert reviewers; Editor makes final decision. Model summary
This journal operates a single anonymized review process. All contributions will be initially assessed by the editor for suitability for the journal. Papers deemed suitable are then typically sent to a minimum of two independent expert reviewers to assess the scientific quality of the paper. The Editor is responsible for the final decision regarding acceptance or rejection of articles. The Editor'…
Source ↗Publisher website ·- Plagiarism Plagiarism
Articles may be checked by Crossref Similarity Check and other originality software. Model summary
All DMPK submissions will be subjected to plagiarism evaluation using the software of iThenticate/Crosscheck prior to editorial processing. Manuscripts that cannot pass the plagiarism evaluation pre-screening will be automatically rejected without review and the plagiarism evaluation will not be provided to authors. For more information, please go to: https://www.elsevier.com/editors/perk/plagiari…
Source ↗Publisher website ·- Preprints Preprints
Preprint sharing allowed anywhere at any time; does not count as prior publication. Model summary
Please note that preprints can be shared anywhere at any time, in line with Elsevier's sharing policy. Sharing your preprints e.g. on a preprint server will not count as prior publication (see 'Multiple, redundant or concurrent publication' for more information).
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Japanese Society for the Study of Xenobiotics
- Country or region
- JAPAN
- Language
- English
- Frequency
- Bimonthly
- Founded
- 2002
- ISSN
- 1347-4367
- Electronic ISSN
- 1880-0920
- Official links
- Journal homepage ↗OpenAlex
- Submission system ↗Publisher website
- Special issues ↗Publisher website
FAQ
Frequently asked questions about Drug Metabolism and Pharmacokinetics
What CAS zone is Drug Metabolism and Pharmacokinetics in?
In the 2025 upgraded edition of the CAS Journal Ranking, Drug Metabolism and Pharmacokinetics is in Zone 4 of Medicine, and in Zone 4 of the minor category Pharmacology & Pharmacy. In the 2026 Xinrui edition it is in Zone 4 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Drug Metabolism and Pharmacokinetics?
The latest impact factor listed by LetPub is 2.13; CiteScore 5.2, h-index 86.
How long does peer review take at Drug Metabolism and Pharmacokinetics?
Based on the dates recorded on 75 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 102 days (interquartile range 62–123 days); authors report an average review time of about 1 month; the community-reported acceptance is “about 75%”. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What are the manuscript requirements of Drug Metabolism and Pharmacokinetics?
According to the journal's author guidelines: Abstract: ≤ 200 words; Keywords: ≥ 5; Manuscript length: ≤ 5,500 words. A model extracted these from the author guidelines and each was checked against the text; check the latest version on the journal's website before submitting.
Where are the editorial board members of Drug Metabolism and Pharmacokinetics based?
Of the 34 board members whose country the journal's board page names, 1 (about 3%) are in mainland China; the countries named most often are Japan (20), South Korea (6) and United States (3). Counted from the institutions listed on the board page; for reference only.
Which databases index Drug Metabolism and Pharmacokinetics?
According to LetPub and DOAJ records, Drug Metabolism and Pharmacokinetics is indexed in SCIE and Scopus. The journal's website also lists PubMed; that list has not been checked against each database.
Is Drug Metabolism and Pharmacokinetics open access, and what is the APC?
Drug Metabolism and Pharmacokinetics is a fully open-access journal. APC about USD 3,580.
Sources and updates
The facts on this page come from LetPub, Publisher website, OpenAlex; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .